Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Mitigation strategies to safely conduct HIV treatment research in the context of COVID-19.
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control.
Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.
Considerations for successful therapeutic immunization in HIV cure.
Incoming HIV virion-derivedGag Spacer Peptide 2 (p1) is a targetof effective CD8+T cell antiviral responses
Absence of drug-drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat.
Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection.
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.
Novel Approaches Towards a Functional Cure of HIV/AIDS.